News for Healthier Living

Immunotherapy Boosts Chemotherapy in Combating Stage 3 Colon Cancer

New research led by Mayo Clinic Comprehensive Cancer Center found that adding immunotherapy to chemotherapy after surgery for patients with stage 3 (node-positive) colon cancer -- and with a specific genetic makeup called deficient DNA mismatch repair (dMMR) -- was associated with a 50% reduction in cancer recurrence and death compared to chemotherapy alone.

June 1, 2025


June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025

June 2 2025

June 1 2025

May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025